Sharps Compliance Corp. Announces Joint Marketing Agreement With McKesson Health Solutions HOUSTON, Oct. 29 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (BULLETIN BOARD: SCOM) ("Sharps") and subsidiaries, leading providers of cost-effective medical waste disposal solutions for industry and consumers, today announced a Joint Marketing Agreement with McKesson Health Solutions. McKesson Health Solutions, a subsidiary of McKesson Corporation, is a leader in the design, implementation and management of marketing programs, specialty pharmaceutical services and patient support centers that help pharmaceutical and biotechnology manufactures successfully commercialize their products. The Joint Marketing Agreement represents a mutually exclusive business arrangement to co-market and sell the Sharps Disposal by Mail System(TM) products and services to pharmaceutical manufacturers and biotechnology companies. This program provides for the safe disposal of used syringes and small quantity medical waste at a facility dedicated for this purpose, transported via the convenience of the United States mail. The Sharps Disposal by Mail System(TM) is designed to protect the community against the potential for accidental needle sticks and the environment from contaminated biomedical waste. This process offers many advantages over current disposal methods which often require patients or their caregivers to personally transport waste materials to a community pick-up site or health care facility. The initial term of the exclusive Agreement is three (3) years. Regarding the announcement, Dr. Burt Kunik, Chairman, Chief Executive Officer and President of Sharps Compliance Corp. stated, "We are very pleased to enter into this Joint Marketing Agreement with a world class organization such as McKesson Health Solutions. We have been extremely impressed with McKesson and our joint opportunity. We look forward to a long-term and mutually successful business arrangement." According to Brian Tyler, president of McKesson Health Solutions, "This agreement will allow us to provide our manufacturer customers with a safe, convenient new tool that they in turn can offer to patients who use their injected medications. The Sharps Disposal by Mail System(TM) fits very well into our comprehensive array of patient support services, and it further enhances our ability to deliver total solutions that help patients effectively manage their therapeutic experience." Kunik added, "The McKesson opportunity expands our business model outside of our core home healthcare, retail and residential markets to the pharmaceutical and biotechnology markets. Our current infrastructure and management team is well suited to efficiently and effectively execute this expansion into new market areas." In addition to the McKesson Agreement, Sharps has existing exclusive manufacturing and distribution agreements through strategic alliances with other industry leading companies, including the Consumer Health Care division of Becton, Dickinson and Company and Waste Management, Inc., to provide cost effective medical waste disposal solutions to diverse market sectors. Headquartered in Houston, Texas, Sharps is a leading developer of superior solutions for improving safety, efficiency and cost related to the proper disposal of medical waste by industry and consumers. The Company's products and services represent cutting edge solutions for a variety of industries dealing with the complexity of managing regulatory compliance, environmental sensitivity, employee and customer safety, corporate risk, and operating costs related to medical waste disposal. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes, and other sharps in the community setting. Sharps Compliance Corp.'s common stock trades on the OTC Bulletin Board under the symbol SCOM. Any forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Act of 1995. Investors are cautioned that actual results may differ substantially from such forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, new products and technological changes, dependence upon third-party vendors, customer relations, government supervision and regulation, changes in industry practices, changes in third-party expense reimbursement procedures, and other risks detailed in the Company's periodic filings with the Securities and Exchange Commission. DATASOURCE: Sharps Compliance Corp. CONTACT: David P. Tusa, Senior Vice President & Chief Financial Officer of Sharps Compliance Corp., +1-713-432-0300, or Web site: http://www.sharpsinc.com/

Copyright